Karl-Erik Andersson to Urinary Incontinence
This is a "connection" page, showing publications Karl-Erik Andersson has written about Urinary Incontinence.
Connection Strength
3.177
-
Koudy Williams J, Dean A, Lankford S, Andersson KE. Efficacy and Initial Safety Profile of CXCL12 Treatment in a Rodent Model of Urinary Sphincter Deficiency. Stem Cells Transl Med. 2017 08; 6(8):1740-1746.
Score: 0.503
-
Andersson KE, Campeau L, Olshansky B. Cardiac effects of muscarinic receptor antagonists used for voiding dysfunction. Br J Clin Pharmacol. 2011 Aug; 72(2):186-96.
Score: 0.333
-
Andersson KE. Tachykinins: role in detrusor overactivity? Eur Urol. 2006 Mar; 49(3):423-5.
Score: 0.226
-
Andersson KE, Wein AJ. Pharmacology of the lower urinary tract: basis for current and future treatments of urinary incontinence. Pharmacol Rev. 2004 Dec; 56(4):581-631.
Score: 0.210
-
Andersson KE. Mechanisms of Disease: central nervous system involvement in overactive bladder syndrome. Nat Clin Pract Urol. 2004 Dec; 1(2):103-8.
Score: 0.210
-
Andersson KE. New pharmacologic targets for the treatment of the overactive bladder: an update. Urology. 2004 Mar; 63(3 Suppl 1):32-41.
Score: 0.199
-
Pehrson R, Stenman E, Andersson KE. Effects of tramadol on rat detrusor overactivity induced by experimental cerebral infarction. Eur Urol. 2003 Oct; 44(4):495-9.
Score: 0.193
-
Christ GJ, Day NS, Day M, Zhao W, Persson K, Pandita RK, Andersson KE. Increased connexin43-mediated intercellular communication in a rat model of bladder overactivity in vivo. . 2003 May; 284(5):R1241-8.
Score: 0.188
-
Andersson KE, Pehrson R. CNS involvement in overactive bladder: pathophysiology and opportunities for pharmacological intervention. Drugs. 2003; 63(23):2595-611.
Score: 0.184
-
Christ GJ, Venkateswarlu K, Day NS, Valcic M, Santizo C, Zhao W, Wang HZ, Persson K, Andersson KE. Intercellular communication and bladder function. Adv Exp Med Biol. 2003; 539(Pt A):239-54.
Score: 0.184
-
Zambon JP, Patel M, Hemal A, Badlani G, Andersson KE, Magalhaes RS, Lankford S, Dean A, Williams JK. Nonhuman primate model of persistent erectile and urinary dysfunction following radical prostatectomy: Feasibility of minimally invasive therapy. Neurourol Urodyn. 2018 09; 37(7):2141-2150.
Score: 0.136
-
Fry CH, Kitney DG, Paniker J, Drake MJ, Kanai A, Andersson KE. Fibrosis and the bladder, implications for function ICI-RS 2017. Neurourol Urodyn. 2018 06; 37(S4):S7-S12.
Score: 0.134
-
Riemsma R, Hagen S, Kirschner-Hermanns R, Norton C, Wijk H, Andersson KE, Chapple C, Spinks J, Wagg A, Hutt E, Misso K, Deshpande S, Kleijnen J, Milsom I. Can incontinence be cured? A systematic review of cure rates. BMC Med. 2017 03 24; 15(1):63.
Score: 0.123
-
Badra S, Andersson KE, Dean A, Mourad S, Williams JK. Long-term structural and functional effects of autologous muscle precursor cell therapy in a nonhuman primate model of urinary sphincter deficiency. J Urol. 2013 Nov; 190(5):1938-45.
Score: 0.094
-
Kanai A, Wyndaele JJ, Andersson KE, Fry C, Ikeda Y, Zabbarova I, De Wachter S. Researching bladder afferents-determining the effects of ß(3) -adrenergic receptor agonists and botulinum toxin type-A. Neurourol Urodyn. 2011 Jun; 30(5):684-91.
Score: 0.082
-
Thüroff JW, Abrams P, Andersson KE, Artibani W, Chapple CR, Drake MJ, Hampel C, Neisius A, Schröder A, Tubaro A. EAU guidelines on urinary incontinence. Eur Urol. 2011 Mar; 59(3):387-400.
Score: 0.079
-
Finney SM, Andersson KE, Gillespie JI, Stewart LH. Antimuscarinic drugs in detrusor overactivity and the overactive bladder syndrome: motor or sensory actions? BJU Int. 2006 Sep; 98(3):503-7.
Score: 0.059
-
Ishizuka O, Gu B, Igawa Y, Nishizawa O, Pehrson R, Andersson KE. Role of supraspinal serotonin receptors for micturition in normal conscious rats. Neurourol Urodyn. 2002; 21(3):225-30.
Score: 0.043